LEADER 02273nam  2200601 a 450 
001 9910778501803321
005 20230207213227.0
010   $a1-280-20356-0
010   $a9786610203567
010   $a0-309-58336-5
010   $a0-585-15547-X
035   $a(CKB)110986584751068
035   $a(OCoLC)559734779
035   $a(CaPaEBR)ebrary10054979
035   $a(SSID)ssj0000151940
035   $a(PQKBManifestationID)11146947
035   $a(PQKBTitleCode)TC0000151940
035   $a(PQKBWorkID)10320453
035   $a(PQKB)10189406
035   $a(MiAaPQ)EBC3375988
035   $a(Au-PeEL)EBL3375988
035   $a(CaPaEBR)ebr10054979
035   $a(CaONFJC)MIL20356
035   $a(OCoLC)923259948
035   $a(EXLCZ)99110986584751068
100   $a19910211d1991      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aExpanding access to investigational therapies for HIV infection and AIDS$b[electronic resource] $eMarch 12-13, 1990, conference summary /$fEve Nichols [writer] ; Roundtable for the Development of Drugs and Vaccines against AIDS, Institute of Medicine
210   $aWashington, D.C. $cNational Academy Press$d1991
215   $a1 online resource (83 p.) 
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-04490-1 
320   $aIncludes bibliographical references.
606   $aAIDS (Disease)$xChemotherapy$xSocial aspects$zUnited States$vCongresses
606   $aPharmacology, Experimental$xSocial aspects$zUnited States$vCongresses
606   $aHIV infections$xChemotherapy$xSocial aspects$zUnited States$vCongresses
615  0$aAIDS (Disease)$xChemotherapy$xSocial aspects
615  0$aPharmacology, Experimental$xSocial aspects
615  0$aHIV infections$xChemotherapy$xSocial aspects
676   $a362.1/969792/00973
700   $aNichols$b Eve K$01548585
712 02$aRoundtable for the Development of Drugs and Vaccines against AIDS (Institute of Medicine)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910778501803321
996   $aExpanding access to investigational therapies for HIV infection and AIDS$93805705
997   $aUNINA